… Prevention of thromboembolic events with oral anticoagulants in nephrotic syndrome … of
the risks for thromboembolic events balanced by the risks for anticoagulant induced bleeding. …

… therapeutic anticoagulation in preventing major thromboembolic … the intensity and duration
of anticoagulation in such patients. … thromboembolic complications and guide anticoagulation …

… -dose prophylactic anticoagulation, compared with standard-dose prophylactic anticoagulation,
… of adjudicated venous or arterial thrombosis, treatment with extracorporeal membrane …

… risk of thrombotic events compared to other ARDS etiologies despite prophylactic anticoagulation
[5… to outcomes with the use of therapeutic anticoagulation versus standard prophylactic …

… the risks and benefits of prophylactic anticoagulant use. The incidence … thrombotic event
prophylaxis, but did describe the use of anticoagulants in patients with NS for thrombotic events …

… The aim of the present study was to delineate the prevalence of thromboembolic events and
the current status of prophylactic anticoagulation therapy in patients with COVID-19 in Japan…

… higher in patients treated with prophylactic anticoagulation when compared with the other
… of thromboembolic events in COVID-19 patients treated with therapeutic anticoagulation, …

… Thromboembolic events are a preventable cause of morbidity and mortality in patients with
… , yet prophylactic anticoagulation is not universally initiated. Prophylactic anticoagulation was …

… be preferred over prophylactic anticoagulation, the monthly rate of venous thrombosis would
have … that the extremely high rate of thromboembolic events justifies the use of prophylactic …

… An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome
(NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no …